SANOFI SYNTHELABO SA 13D and 13G filings for Telesis Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2021-08-12 4:00 pm Sale |
2021-08-02 | 13D | Telesis Bio, Inc. TBIO |
SANOFI SYNTHELABO SA | 204,691 4.900% |
-66,667![]() (-24.57%) |
Filing |
2021-02-04 06:57 am Purchase |
2020-07-20 | 13G | Telesis Bio, Inc. TBIO |
SANOFI SYNTHELABO SA | 271,357 6.600% |
271,357![]() (New Position) |
Filing |